Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.
(NAEVR) held its Fourth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill and twenty early-stage investigators participated.
Research to Prevent Blindness (RPB) and Lions Clubs International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.
Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research
RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.
RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.
The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.
Award recipients to use IRIS Registry database to conduct population-based studies.
Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.
RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
RPB celebrates five decades of sight-saving discoveries at NEI.
RPB hosted its fifth annual convening of organizations that fund vision research in Washington DC.
Partnership to utilize IRIS Registry database to advance patient care.
RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.
RPB-supported researchers make progress in characterizing the genetic components of Usher syndrome.
The model will allow researchers to better assess treatments for this hard-to-study cause of blindness.
The findings may have significant therapeutic implications for AMD, the most common cause of elderly blindness in the developed world
RPB-supported researchers at the University of Illinois at Chicago have identified an enzyme present in the cornea that triggers inflammation during and even after a herpes virus infection.
New RPB-supported research provides hope for transplants of neural stem cells as future treatment for brain injuries.
Dry eye, a global problem affecting more than 30 million people in the U.S. alone, occurs when the eye does not produce tears properly or when the tears are not of the correct consistency and evaporate too quickly.
The RPB-supported researchers hope their finding will lead to tests to identify cell damage before irreversible vision loss.
More than 30 private and public funders of vision research came together in Washington DC to discuss ways to maximize their support of scientific research in light of new recommendations and a changing environment.
An RPB Trustee pens a powerful Op-Ed on the need to support scientific research through the National Institutes of Health.
|General Info||Research Scientists & Grantees||Eye Care Specialists||Donors & Partners|